Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


Coil reactors - Homogeneous Reactions

Product Description

Cylinders.gifUniqsis offers interchangeable coil reactors in a range of sizes (2 ml to 20 ml) and materials (perfluoropolymer, stainless steel, Hastelloy?). These are fabricated from 1 mm internal diameter tubing wound onto an aluminium mandrel.

Smaller volume coils can be utilised for optimisation minimising material usage. Larger coils meet the requirements for scale up or longer residence times. Additional coil reactor volumes can be obtained by winding with tubing of diffferent internal dimensions.

The coil reactors are mounted on a purpose-built heated reactor module and can be changed in seconds. Reaction temperatures can be accurately controlled up to 260 °C.

Coil reactors can be re-wound if necessary (for example if they they are inadvertently blocked and can't be cleared). Note: When using perfluoropolymer tubing, this should be replaced periodically as a matter of course since it becomes 'fatigued' after repeated heat and pressure cycling. 

Benefits

  • Flexible - A range of materials and sizes are available for maximum chemical compatibility
  • Safety - FlowSyn limits temperature and pressure limit based on the coil material
  • High Performance - Coil design ensures excellent heat transfer
  • Visibility - Reactions performed in perfluoropolymer tubing are clearly visible through the glass coil cover
Features
  • Sizes from 2 ml to 20 ml available
  • LT Teflon for temps up to 100 °C
  • HT Teflon for temps up to 150 °C
  • Stainless steel or Hastelloy for temps up to 260 °C
Product Coil reactors - Homogeneous Reactions
Company Uniqsis
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Uniqsis
29 Station Road Shepreth Cambridgeshire SG8 6GB UK

Tel: +44 (0)845 864 7747

Email: info@uniqsis.com



Scientific News
Combining Chemotherapy With Immune-Blocking Drug Could Stop Cancer Growing Back
Giving patients a drug that blocks part of the immune system from going into overdrive might help prevent cancer coming back in some people.
Researchers Pioneer Use of Capsules to Save Materials
Wax capsule delivery systems can simplify a wide range of chemistry transformations.
Photoredox Catalyst Unlocks New Pathways for Nickel Chemistry
Using a light-activated catalyst, researchers have unlocked a new pathway in nickel chemistry to construct carbon-oxygen (C-O) bonds that would be highly valuable to pharmaceutical and agrochemical industries.
Scientists Determine How Antibiotic Gains Cancer-Killing Sulfur Atoms
In a discovery with implications for future drug design scientists have shown an unprecedented mechanism for how a natural antibiotic with antitumor properties incorporates sulfur into its molecular structure, an essential ingredient of its antitumor activity.
Familiar Drugs May Block Ebola Virus Infection
A well-known class of molecules, many of which are already in use therapeutically, may be able to block the Ebola virus’s entry into cells and halt the disease in its tracks, according to researchers at the University of Illinois at Chicago.
New Extra ‘Sticky’ Microgel Could Revolutionise Bladder Cancer Treatment
Researchers have designed a new super-efficient way of delivering an anti-cancer drug which could extend and improve the quality of life for bladder cancer patients - and perhaps save lives.
Common Class of ‘Channel Blocking’ Drugs May Find a Role in Cancer Therapy
Discoveries in fruit flies prompt unusual treatment of patient with metastatic disease.
Common Medications Could Delay Brain Injury Recovery
Drugs used to treat common complaints could delay the recovery of brain injury patients according to research by University of East Anglia (UEA) and University of Aberdeen scientists, published today in Brain Injury.
Scientists Make Strides in Therapy Preventing Addiction Relapse
Single Injection of Drug Candidate Prevents Meth Relapse in Animal Models.
New Clot-Busting Treatments Target Number One Killer
Australian researchers funded by the National Heart Foundation are a step closer to a safer and more effective way to treat heart attack and stroke via nanotechnology.

Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!